Addus Homecare Co. (NASDAQ:ADUS) insider W Bradley Bickham sold 15,000 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $80.67, for a total transaction of $1,210,050.00. Following the completion of the transaction, the insider now owns 38,311 shares in the company, valued at $3,090,548.37. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Shares of ADUS opened at $83.46 on Thursday. The company has a current ratio of 2.84, a quick ratio of 2.87 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $1.10 billion, a price-to-earnings ratio of 49.38, a PEG ratio of 2.55 and a beta of -0.10. The business’s 50 day simple moving average is $78.53. Addus Homecare Co. has a 12-month low of $56.75 and a 12-month high of $84.99.
Addus Homecare (NASDAQ:ADUS) last announced its earnings results on Monday, August 5th. The company reported $0.47 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.47. The business had revenue of $149.69 million for the quarter, compared to analyst estimates of $146.66 million. Addus Homecare had a net margin of 3.31% and a return on equity of 8.55%. As a group, analysts expect that Addus Homecare Co. will post 2.11 earnings per share for the current fiscal year.
Several equities analysts have commented on the stock. Zacks Investment Research lowered shares of Addus Homecare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. BMO Capital Markets set a $85.00 price target on shares of Addus Homecare and gave the company a “hold” rating in a research note on Wednesday, August 7th. Sidoti increased their price target on shares of Addus Homecare from $84.00 to $96.00 and gave the company a “buy” rating in a research note on Tuesday, August 6th. Oppenheimer increased their price target on shares of Addus Homecare from $80.00 to $91.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Finally, Raymond James set a $92.00 target price on shares of Addus Homecare and gave the stock an “outperform” rating in a research report on Wednesday, August 7th. Two research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $83.44.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Recommended Story: Special Dividends
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.